1) Lancaster E:Paraneoplastic disorders. Continuum (Minneap Minn) 2015;21:452-75 2) Dalmau J, Rosenfeld MR:Autoimmune encephalitis update. Neuro Oncol 2014;16:771-8 3) Dalmau J, Lancaster E, Martinez-Hernandez E, et al:Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74 4) Vincent A, Bien CG, Irani SR, Waters P:Autoantibodies associated with diseases of the CNS:new developrnents and future challenges. Lancet Neurol 2011;10:759-72 5) Lancaster E, Huijbers MG, Bar V, et al:Investigations of Caspr2, an-autoantigen of encephalitis and neuromyotorlia. Ann Neurol 2011;69:303-11 6) Lai M, Hughes EG, Peng X, et al:AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-34 7) Lai M, Huijbers MGM, Lancaster E, et al:Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels:a case series. Lancet Neurol 2010;9:776-85 8) Hutchinson M, Waters P, McHugh J, et al:Progressive encephalomyelitis, rigidity, and myoclonus:a novel glycine receptor antibody. Neurology 2008;71:1291-2 9) Saiz A, Blanco Y, Sabater L, et al:Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies:diagnostic clues for this association. Brain 2008;131:2553-63